HOME >> MEDICINE >> NEWS
Vaccine may complement conventional treatment for chronic leukaemia

A vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia (CML), suggest early results of a trial published in this week's issue of THE LANCET.

CML is caused by the breakage and swapping of chromosomes 9 and 22, which results in a shortened chromosome called the Philadelphia chromosome. Cells with the abnormal chromosome make a protein that encourages aberrant growth and division. Patients with CML can be treated with a drug called imatinib or interferon alfa. Treatment with imatinib can lead to complete cytogenetic remission, where no Philadelphia chromosomes are detected during cell division. However, a complete molecular response, where there is no evidence of the protein produced by the Philadelphia chromosomes, is rare.

Monica Bocchia (University of Siena, Italy) and colleagues tested whether a vaccine that targets a protein derived from the Philadelphia chromosome could help to eradicate the disease in patients. The investigators enrolled 16 individuals (10 patients on imatinib and 6 on interferon) with stable, but detectable disease into the trial. Patients were given one dose (six injections) of the protein vaccine every 2 weeks while they continued their conventional treatment. Patients were assessed before vaccination and after three and six doses for evidence of the disease.

Nine patients on imatinib showed progressive reduction of their residual disease after three and six doses of the vaccine with five patients reaching complete cytogenetic remission. Three of the five patients also obtained undetectable disease at a molecular level. Of the six patients on interferon alfa, five showed a reduction of their stable disease during vaccinations, with two reaching complete cytogenetic remission.

Dr Bocchia comments: "Our preliminary data suggest that the addition of this vaccine to patients treated with conventional treatment might favour further
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
17-Feb-2005


Page: 1 2

Related medicine news :

1. Vaccine against childhood pneumonia shows promise
2. Vaccine preparedness, or not
3. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
4. Vaccine reduces racial disparity in incidence of childhood pneumonia and meningitis
5. Vaccine nips breast cancer in the bud
6. Vaccine shows promise for kidney cancer
7. Vaccine development against influenza A (h5n1) virus should be made a priority
8. Vaccines against fatal African cattle fever
9. Vaccine development sparks debate on changes to cervical cancer screening guidelines
10. Vaccine shortage study exposes nations patchwork system
11. Vaccines prevent cancers of the liver and cervix

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... ... ... CBD Hacker , the definitive guide to the CBD industry, has named ... of rigorous testing of more than 20 products, including third-party potency testing, hands-on evaluations, ... a fast-acting, effective delivery method for CBD. And the fact that it’s a highly ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... possibility of another shutdown looming, the American Academy of Sleep Medicine (AASM) is ... fatigue among air traffic controllers and Transportation Security Administration (TSA) officers. , “Even ...
(Date:2/13/2019)... ... 13, 2019 , ... With Valentine’s Day tomorrow and love in the air, ... sharing 7 tips to ensure ‘Safe Sex’: , 1. Talk To Your Partner. ... safe sex. Having clear, open, and honest communication is key so that both partners ...
(Date:2/13/2019)... ... February 13, 2019 , ... Diameter Health , the leader in ... Federal Information Security Management Act (FISMA) High General Support System Authority to Operate (ATO) ... environment is mandatory for the VA because of their work with confidential patient data. ...
(Date:2/13/2019)... ... February 13, 2019 , ... Castle announced today that it has raised ... investors Y Combinator , First Round and F-Prime Capital Partners ... René Bonvanie, CMO at Palo Alto Networks, and Olivier Pomel, CEO at Datadog. This ...
Breaking Medicine News(10 mins):
(Date:2/16/2019)... ... February 15, 2019 , ... Adolfson ... Program (MNSHARP) award for safety excellence. Commissioner Kristin Batson, Department of Labor and ... , Safety is more than just a set of rules for AP; it’s ...
(Date:2/14/2019)... BOULDER, Colo. (PRWEB) , ... February 14, 2019 ... ... the Month , Lewis and Clark College Emeritus Professor of Education Gregory A. ... Center. They discuss the emergence of Brand Ambassador programs, a new phenomenon in ...
(Date:2/14/2019)... ... February 14, 2019 , ... Strategic Radiology announces its ... Asheville, North Carolina. , “We are excited to welcome the physicians and ... Radiology,” said Arl Van Moore Jr, MD, Strategic Radiology CEO and Chair. “When ...
Breaking Medicine Technology:
Cached News: